|
|||||
|
|
First-trimester contingent screening for Down syndrome can reduce the number of nuchal translucency measurements required |
|
| Authors: | Thenmalar Vadiveloo Jennifer A. Crossley David A. Aitken |
| Affiliation: | Biochemical Genetics Department, Institute of Medical Genetics, Yorkhill, Glasgow G3 8SJ, UK |
| Abstract: | |
| Keywords: | prenatal screening Down syndrome serum markers nuchal translucency first trimester |